DBV Technologies : Announces Filing of its 2016 "Document

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
101
DBV Technologies : Announces Filing of its 2016 "Document de Référence" and Annual Report on Form 20-F
Press Release Montrouge, France, March 22, 2017

DBV Technologies Announces Filing of its 2016 "Document de Référence" and Annual Report on Form 20-F

                                                                                                                                                                      

DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced the filing of its 2016 Annual Report " Document de Référence " for the year ended December 31, 2016 with the French market authority " Autorité des Marchés Financiers " (AMF) and the filing of its Annual Report on Form 20-F for the year ended December 31, 2016 with the U.S. Securities and Exchange Commission (SEC).

These documents can be accessed on the Investor Relations section of the Company's website at www.dbv-technologies.com . In addition, the " Document de Référence " is available on the AMF's website at www.amf-france.org and the Form 20-F is available on the SEC's website at www.sec.gov . Printed copies of the "Document de Référence" are available at the Company's headquarters and registered office located at 177-181 avenue Pierre Brossolette 92120 Montrouge, France. Any shareholder can request a printed copy of the Form 20-F, free of charge, upon request. Requests should be directed to DBV Technologies, Attn: Investor Relations, 177-181 avenue Pierre Brossolette 92120 Montrouge, France.

About DBV Technologies DBV Technologies is developing Viaskin®, a proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT®, DBV's method of delivering biologically active compounds to the immune system through intact skin. With this new class of self-administered and non-invasive product candidates, the company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV's food allergies programs include ongoing clinical trials of Viaskin Peanut and Viaskin Milk, and preclinical development of Viaskin Egg. DBV is also pursuing a human proof-of-concept clinical study of Viaskin Milk for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other immune diseases. DBV Technologies has global headquarters in Montrouge, France and New York, NY. Company shares are traded on segment A of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and traded on the Nasdaq Global Select Market in the form of American Depositary Shares (each representing one-half of one ordinary share) (Ticker: DBVT). For more information on DBV Technologies, please visit our website: www.dbv-technologies.com

DBV Technologies Contact Susanna Mesa Senior Vice President, Strategy +1 212-271-0861 susanna.mesa@dbv-technologies.com

Media Contact Andrea Fassacesia, Weber Shandwick +1 212-445-8144 afassacesia@webershandwick.com

Media Contact Europe Caroline Carmagnol, Alize RP, Relations Presse +33 (0)6 64 18 99 59  caroline@alizerp.com

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...5ae7eb1cf9

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IWP and SHARE Forge New Path for Filmmaker Funding

Updated Category News Views 4

Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...

Continue Reading
Key Insights for Launching a Mobile Grooming Biz

Updated Category News Views 4

Riding the Mobile Revolution with Grooming Anyone who's dabbled in grooming knows that moving to a mobile setup isn’t just about freedom and flexibility—it's a whole new ballgame. We're talking Chris Hanvey-level insights here, direct from Easley, S.C. This ain't your average jump in a van and snip some fur operation. Choosing the Right Rig First on the list: the...

Continue Reading
Apex Dental's Growth Shines in Inc. 5000 Ranking

Updated Category News Views 5

Another Year, Another Milestone for Apex Dental Let's talk about steady growth. Apex Dental Partners has made it onto the Inc. 5000 list for the eighth straight year, landing at No. 3,850. Quite a feat, considering this list only features America's fastest-growing private companies. Apex isn't just maintaining its position out of sheer luck. Revenue shot up by 67% over...

Continue Reading
Infrared Imaging Expands with AI, SWIR: Tech Trends

Updated Category News Views 5

Infrared Imaging: The Backbone of Future Tech Kinda wild how infrared imaging's become a hot topic in tech circles. With the market expected to jump from USD 9.2 billion in 2026 to a hefty USD 12.6 billion by 2031, averaging a 6.4% growth rate, there's plenty to chew on. Even if you ain't the analytical type, it ain't hard to spot where the money's flowing. Infrared's...

Continue Reading
Flux Expands AI Platform to Prove Engineering ROI

Updated Category News Views 7

Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...

Continue Reading
Hi-Tech's Dubai Chocolate Adds Flavor to Sales Surge

Updated Category News Views 4

Ever found a protein shake that tastes like a candy bar from the future? Well, Hi-Tech Pharmaceuticals is banking on their new Dubai Chocolate flavor to hit that sweet spot. This isn't your typical powdered shake game; Hi-Tech's been cranking the flavor dial ever since they introduced their Precision Protein® line back in 2016. They've carved out a niche with unique...

Continue Reading
Class Action Lawsuit Targets Lincoln Educational Services

Updated Category News Views 4

Legal Maneuver Against Lincoln Educational Services Here we go again—another day, another lawsuit. The recent flap with Lincoln Educational Services Corporation (NASDAQ: LINC) is as classic as any market rug pull. Stepping into the spotlight, Wolf Haldenstein Adler Freeman & Herz LLP—a courtroom icon since 1888—has announced a class action lawsuit against Lincoln....

Continue Reading
Foodsmart's Program Links Food Benefits to Health Gains

Updated Category News Views 3

Navigating the healthcare maze isn't for the faint of heart, especially when it comes to making sure that dollars spent on food benefits actually translate to improved health. Enter Foodsmart, the foodcare powerhouse that just rolled out its Food-is-Medicine Benefits Management (FBM) program. Turning Meals into Measurable Metrics Health plans are under mounting pressure...

Continue Reading
Navigating Hit and Run Protocols in St. Tammany Parish

Updated Category News Views 3

When the Driver Disappears: Steps Forward Hit and run accidents can leave you feeling abandoned and unsure of what to do. In St. Tammany Parish, this scenario is all too familiar. Personal Injury Attorney Ross F. Lagarde cuts through the chaos, offering a clear path for those caught in this nightmare, explained in HelloNation's comprehensive guide. Prioritize Safety and...

Continue Reading
Bay Crane's Bold Auction: A Strategic Fleet Update

Updated Category News Views 2

Bay Crane's Big Move: Strategic Fleet Update through Auction Well, here's a twist that gets the pulse racing for industry folk and machinery buffs. Bay Crane Companies, a powerhouse in the crane and hauling sector, has decided to go all in on a strategic fleet update. And what better way to move that iron than with a live, no-reserve auction? They've tapped Jeff Martin...

Continue Reading

Top 5 Most Recently Viewed Articles

Atkore Inc. Reports First Quarter 2025 Financial Performance

Updated Category News Views 159

Atkore Inc. Financial Performance Overview Atkore Inc. recently shared its financial results for the first quarter of fiscal 2025, covering the period ending December 27, 2024. The report revealed a significant impact from various market challenges, yet highlighted ongoing trends in sales sources. Sales and Earnings Report During this quarter, Atkore experienced a...

Continue Reading
Transforming Multifamily Housing: Identity Verification Alliance Emerges

Updated Category News Views 134

Launch of New Multifamily Fraud Prevention Alliance The multifamily housing sector is entering an exciting new chapter with the formation of a groundbreaking fraud prevention alliance. This initiative marks a significant step towards enhancing identity verification processes across the industry, setting a standard for safety and security. In a move that symbolizes...

Continue Reading
Holiday Sales Data Reveals Technology Spending Surge

Updated Category News Views 102

Holiday Season Technology Sales Trends As the holiday season gathers momentum, consumers have been actively engaging with retailers both online and in physical stores. Recent retail sales data indicates a notable increase in technology product spending during prominent shopping periods, specifically Black Friday and Cyber Monday. With a reported growth of 3.5% in total...

Continue Reading
SolarWinds Expands Globally with New Office Plans in Riyadh

Updated Category News Views 183

SolarWinds Announces Plans for Riyadh Office in 2025 SolarWinds Corp (NYSE: SWI) is set to establish a new office in Riyadh, Saudi Arabia, by the year 2025. This move is driven by the increasing demands for advanced technology and robust investment opportunities in the region. Continued Growth Since Dubai Office Opening The company has experienced double-digit annual...

Continue Reading
Teva and Samsung Bioepis Launch Affordable Biosimilar EPYSQLI

Updated Category News Views 281

Exciting Launch of EPYSQLI (eculizumab-aagh) for Rare Diseases Teva Pharmaceuticals, a well-established name in the biopharmaceutical industry, in collaboration with Samsung Bioepis, has announced a significant development in the treatment for rare diseases. The introduction of EPYSQLI (eculizumab-aagh) provides a new option for patients facing paroxysmal nocturnal...

Continue Reading